BILIARY TRACT NEOPLASMS
Clinical trials for BILIARY TRACT NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new BILIARY TRACT NEOPLASMS trials appear
Sign up with your email to follow new studies for BILIARY TRACT NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets tough cancers with KRAS mutation
Disease control Recruiting nowThis study tests a new drug, LY3537982, in people with advanced solid tumors that have a specific genetic change called KRAS G12C. The goal is to see if the drug is safe and shrinks tumors. About 540 adults with lung, colon, endometrial, ovarian, pancreatic, or bile duct cancers …
Matched conditions: BILIARY TRACT NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 08:46 UTC
-
New pill combo aims to stall bile duct cancer when standard care fails
Disease control Recruiting nowThis study tests a new two-drug combination (trifluridine/tipiracil pills plus oxaliplatin IV) in 27 people with advanced biliary tract cancer whose first chemotherapy stopped working or didn't help. The goal is to see if this combo can keep the cancer from growing better than th…
Matched conditions: BILIARY TRACT NEOPLASMS
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:31 UTC
-
Personalized cancer treatment may extend life for biliary cancer patients
Disease control Recruiting nowThis study tests whether giving a targeted therapy after initial chemotherapy can help people with advanced biliary cancer live longer without their disease getting worse. About 800 participants will first have their tumor genetically tested. Those with a targetable change and st…
Matched conditions: BILIARY TRACT NEOPLASMS
Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: BILIARY TRACT NEOPLASMS
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
Tissue bank study aims to unlock secrets of rare cancer
Knowledge-focused Recruiting nowThis study collects blood, urine, tumor samples, and health information from up to 1,000 people with malignant mesothelioma and other cancers that express mesothelin. The goal is to build a tissue bank for future research, not to test a new treatment. Participants must be at leas…
Matched conditions: BILIARY TRACT NEOPLASMS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 08:43 UTC